MMD2
Monocyte to macrophage differentiation factor 2
Also known as: PAQR10, PAQRA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IY49
- Gene
- MMD2
- Ensembl
- ENSG00000136297
- Chromosome
- 7
- Canonical length
- 270 aa
- Protein class
- Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a member of the PAQR (progestin and adipoQ receptor) family. Members of this family are evolutionarily conserved with significant sequence identity to bacterial hemolysin-like proteins and are defined by a set of seven transmembrane domains. The protein encoded by this gene localizes to the Golgi apparatus to modulate Ras signaling. Alternative splicing results in multiple transcript variants and protein isoforms. [provided by RefSeq, Jun 2012]
Canonical amino-acid sequenceUniProt
270 residues, UniProt reviewed canonical sequence.
>Q8IY49|MMD2
1 MFAPRLLDFQ KTKYARFMNH RVPAHKRYQP TEYEHAANCA THAFWIIPSI LGSSNLYFLS
61 DDDWETISAW IYGLGLCGLF VVSTVFHTIS WKKSHLRMVE HCLHMFDRMV IYFFIAASYA
121 PWLNLRELGP WASHMRWLVW IMASVGTIYV FFFHERTGSC VQFLRGEACP KAGTACLPAR
181 YKLVELLCYV VMGFFPALVI LSMPNTEGIW ELVTGGVFYC LGMVFFKSDG RIPFAHAIWH
241 LFVAFGAGTH YYAIWRYLYL PSTLQTKVSKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MMD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 28 nTPM
- cerebral cortex: 22 nTPM
- basal ganglia: 19 nTPM
- amygdala: 17 nTPM
- midbrain: 12 nTPM
- hippocampal formation: 12 nTPM
Single-cell type
- sertoli cells: 443 nCPM
- astrocytes: 308 nCPM
- oligodendrocyte progenitor cells: 194 nCPM
- cone photoreceptor cells: 170 nCPM
- lactotrophs: 156 nCPM
- bergmann glia: 139 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 66 nTPM
- medulla oblongata: 65 nTPM
- basal ganglia: 63 nTPM
- midbrain: 59 nTPM
- amygdala: 59 nTPM
- hippocampal formation: 55 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.42
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.12
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
OntologyGO
Biological processes
- positive regulation of neuron differentiation
- positive regulation of protein kinase activity
- positive regulation of Ras protein signal transduction
- regulation of protein localization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MMD2 as an antibody target. Whether an autoantibody or antibody against MMD2 could matter depends on whether native MMD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MMD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MMD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...